MedEffect e-Notice from Health Canada | Nintedanib vs Green Tea Extract

On January 11, 2018, Health Canada released a MedEffect Notice regarding OFEV (Nintedanib), a drug manufactured by Boehringer Ingelheim (Canada) Ltd., which is used for the treatment of Idiopathic Pulmonary Fibroses (a type of lung disease). The drug, released October...